Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 2006
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagusUta Reichelt, Peer Duesedau, Maria Ch Tsourlakis, et al.
Nature Communications|March 24, 2023
IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass CytometryPeng Lu, Karolyn A Oetjen, Diane E Bender, et al.
British Journal of Haematology|May 12, 2010
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapyPhilip S Rosenberg, Cornelia Zeidler, Audrey A Bolyard, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
PTEN regulates natural killer cell trafficking in vivoJeffrey W Leong, Stephanie E Schneider, Ryan P Sullivan, et al.
Injury|December 3, 2020
Plate vs. nail for extra-articular distal tibia fractures: How should we personalize surgical treatment? A meta-analysis of 1332 patientsN J Bleeker, B J M van de Wall, F F A IJpma, et al.
Blood|October 29, 2014
Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in miceElise Peterson Lu, Michael McLellan, Li Ding, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2014
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancerRoheena Z Panni, Dominic E Sanford, Brian A Belt, et al.
Blood|March 28, 2009
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activityBenjamin J Capoccia, Debra L Robson, Krysta D Levac, et al.
British Journal of Haematology|November 22, 2007
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropeniaPhilip S Rosenberg, Blanche P Alter, Daniel C Link, et al.
Blood Advances|January 29, 2026
Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AMLJeremy T Baeten, Sumedha Agashe, Imene Tabet, et al.
Pageof 30